Package 70385-2033-1

Brand: naloxone hydrochloride

Generic: naloxone hydrochloride
NDC Package

Package Facts

Identity

Package NDC 70385-2033-1
Digits Only 7038520331
Product NDC 70385-2033
Product ID 70385-2033_48355744-9af7-05f7-e063-6294a90ae4a0
Description

1 VIAL in 1 PACKAGE (70385-2033-1) / 1 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2017-08-08
Brand naloxone hydrochloride
Generic naloxone hydrochloride
Sample Package No

Linked Drug Pages (1)

Naloxone Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "48355744-9af7-05f7-e063-6294a90ae4a0", "openfda": {"upc": ["0370069071014"], "unii": ["F850569PQR"], "rxcui": ["1659929"], "spl_set_id": ["2879294f-9af9-459e-e063-6394a90a0820"], "manufacturer_name": ["Sina Health Inc"]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 PACKAGE (70385-2033-1)  / 1 mL in 1 VIAL", "package_ndc": "70385-2033-1", "marketing_start_date": "20170808"}], "brand_name": "Naloxone Hydrochloride", "product_id": "70385-2033_48355744-9af7-05f7-e063-6294a90ae4a0", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "70385-2033", "generic_name": "Naloxone Hydrochloride", "labeler_name": "Sina Health Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naloxone Hydrochloride", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".4 mg/mL"}], "application_number": "ANDA207633", "marketing_category": "ANDA", "marketing_start_date": "20170808", "listing_expiration_date": "20271231"}